LBW did not represent a risk factor in the occurrence of MetS or endothelial dysfunction in adolescence.
The aim of this paper is to identify the prevalence of the most frequent drug interactions in patients using oral antidiabéticos and their association with capillary glucose and medication adherence. In total, 579 type 2 diabetes mellitus patients from 12 health institutions in Fortaleza, Brazil were interviewed in 2009. A form was applied, including questions on medication use, comorbidities, lifestyle, body mass index and random capillary glucose. Results revealed that 26.7% used five or more different drugs simultaneously and daily. Statistically significant drug interactions occurred between antidiabéticos and diuretics, angiotensin-converting enzyme inhibitors, anti-lipidaemics and corticoids. No significant association was found between polypharmacy, medication adherence and glucose. It is important for nurses, in consensus with other health professionals, to consider the possibility of other drugs that mean less risk for diabetes patients' glucose control or of increased antidiabetics doses.
This research aimed to relate medication use with blood glucose and body mass index in subjects with type 2 diabetes mellitus. It was performed a cross-sectional study, between January and July 2009, at the homes of 437 users of 12 health centers in Fortaleza-CE. We administered a survey about blood glucose, body mass index and medication use. Approximately 99% of study subjects with altered glucose classified as not using daily calcium (p = 0.04). Among those with normal blood glucose levels classified as around 93% did not use daily antidepressants / anxiolytics (p = 0.02). Among those with DM 2 normal body mass index, 45.5% were using daily anti-hypertensive ACE-inhibitor class (p = 0.03). Daily use of ACE inhibitor drugs, antidepressants / anxiolytics and calcium was associated with body mass index and glucose, respectively. It is important for nurses to assess body weight and blood glucose in patients with diabetes, particularly those that are under continuous medication.
Keywords► low birth weight ► cardiovascular disease risk factors ► anthropometry ► low socioeconomic status ► adolescence AbstractPurpose Previous studies have shown that low birth weight (LBW) is associated with cardiovascular risk in late adulthood. Recent studies in adolescents suggest that modifiable factors may have greater influence on increased cardiovascular risk. This study aims to investigate the association between LBW and changes in anthropometric and biochemical risk factors during adolescence in a population with low average socioeconomic status. Methods In a retrospective double cohort, data of birth weight were extracted from hospital records of children born on the same day between 1992 and 2002. According to the World Health Organization, we classified the children as having LBW or normal birth weight. A total of 172 subjects among children, adolescents and adults were researched. We measured anthropometric and clinical data, lipid profile and glucose after an overnight fasting. The low and normal weight groups were compared using Mann-Whitney U, Fischer exact, Chi-square ( 2) and Student's t tests. Results Pregnant women with preeclampsia delivered more newborns with LBW (p < 0.001). Anthropometric and clinical parameters were similar between groups. No differences were found in the family history of cardiovascular diseases (p ¼ 0.1), family incomes (p ¼ 0.8) and maternal school education (p ¼ 0.8) between groups. Conclusion In this study, LBW did not increase cardiovascular disease risk factors in adolescents. We observed absence of association between low birth weight and poor health outcomes among adolescents with low socioeconomic status from an urban city in the Brazilian northeast.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.